Skip to main content
Erschienen in: European Radiology 5/2021

17.10.2020 | Ultrasound

Absent atherosclerotic risk factors are associated with carotid stiffening quantified with ultrafast ultrasound imaging

verfasst von: Zheng-Qiu Zhu, Ling-Shan Chen, Xue-Zhong Jiang, Yi-Yun Wu, Chong Zou, Yun Luan, Hui Gao, Ping Dai, Xue-Hui Ma, Lin-Lin Wu, Hui-Juan Sun, Yin-Ping Wang, Fei Zou, Fu-Ming Liu, Hui Huang

Erschienen in: European Radiology | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate carotid stiffening in participants without conventional cardiovascular risk factors (CVRFs) by using ultrafast pulse wave velocity (ufPWV).

Methods

The present study enrolled 517 participants without conventional CVRFs (CVRF-Free total population). Subjects in this population were defined as current non-smokers with untreated blood pressure < 140/90 mmHg, fasting blood glucose (FBG) < 7.0 mmol/L, total cholesterol (TC) < 6.2 mmol/L, low-density lipoprotein cholesterol < 4.1 mmol/L, and high-density lipoprotein cholesterol ≥ 1.0 mmol/L. Participants in the subgroup with optimal CVRFs (CVRF-Optimal subgroup; n = 188) were defined as having blood pressure < 120/80 mmHg, TC < 5.2 mmol/L, and FBG < 5.6 mmol/L. Clinical interviews, physical examinations, serum draw, carotid intima-media thickness (cIMT), and ufPWV were evaluated. Adjusted odds ratios (ORs) with 95% confidence intervals and ordinal logistic regression models were used.

Results

Carotid stiffening was present in 46.2–54.5% of CVRF-Free subjects. Age, male sex, and body mass index (BMI) were independently associated with carotid stiffening in both the CVRF-Free total population and CVRF-Optimal subgroup (OR for age = 1.10–1.11, OR for male sex = 2.65–7.19, OR for BMI = 1.34–1.62; p < 0.05). Carotid stiffening was associated with TC only in the CVRF-Free total population (OR for TC = 1.84; p = 0.034).

Conclusions

Many CVRF-Free individuals have carotid stiffening. ufPWV for atherosclerotic stiffening aids the assessment of early atherogenesis and may further clarify the true status of healthy adults without CVRFs.

Key Points

CVRF-Optimal individuals have a lower carotid stiffness than CVRF-Free populations.
ufPWV is a quantitative predictor for the early assessment of AS.
Absent major CVRFs cannot be considered low risk for carotid stiffening and atherosclerosis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Khot UN, Khot MB, Bajzer CT et al (2003) Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290:898–904CrossRef Khot UN, Khot MB, Bajzer CT et al (2003) Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290:898–904CrossRef
2.
Zurück zum Zitat George MG, Tong X, Bowman BA (2017) Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA Neurol 74:695–703CrossRef George MG, Tong X, Bowman BA (2017) Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA Neurol 74:695–703CrossRef
3.
Zurück zum Zitat Fernández-Friera L, Fuster V, López-Melgar B et al (2017) Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors. J Am Coll Cardiol 70:2979–2991CrossRef Fernández-Friera L, Fuster V, López-Melgar B et al (2017) Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors. J Am Coll Cardiol 70:2979–2991CrossRef
4.
Zurück zum Zitat Piepoli MF, Hoes AW, Agewall S et al (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 252:207–274CrossRef Piepoli MF, Hoes AW, Agewall S et al (2016) 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 252:207–274CrossRef
5.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219CrossRef Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219CrossRef
6.
Zurück zum Zitat Baber U, Mehran R, Sartori S et al (2015) Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol 65:1065–1074CrossRef Baber U, Mehran R, Sartori S et al (2015) Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study. J Am Coll Cardiol 65:1065–1074CrossRef
7.
Zurück zum Zitat Yeboah J, McClelland RL, Polonsky TS et al (2012) Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308:788–795CrossRef Yeboah J, McClelland RL, Polonsky TS et al (2012) Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308:788–795CrossRef
8.
Zurück zum Zitat Gonzalez-Cantero A, Gonzalez-Cantero J, Sanchez-Moya AI, Rodriguez-Padial L, Perez-Hortet C, Gonzalez-Calvin JL (2019) Is intima-media thickness a predictor for cardiovascular risk? Lancet 394:380–381CrossRef Gonzalez-Cantero A, Gonzalez-Cantero J, Sanchez-Moya AI, Rodriguez-Padial L, Perez-Hortet C, Gonzalez-Calvin JL (2019) Is intima-media thickness a predictor for cardiovascular risk? Lancet 394:380–381CrossRef
9.
Zurück zum Zitat Gepner AD, Young R, Delaney JA et al (2015) Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 8:e002262CrossRef Gepner AD, Young R, Delaney JA et al (2015) Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 8:e002262CrossRef
10.
Zurück zum Zitat Den Ruijter HM, Peters SA, Anderson TJ et al (2012) Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 308:796–803CrossRef Den Ruijter HM, Peters SA, Anderson TJ et al (2012) Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 308:796–803CrossRef
11.
Zurück zum Zitat Lorenz MW, Polak JF, Kavousi M et al (2012) Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 379:2053–2062CrossRef Lorenz MW, Polak JF, Kavousi M et al (2012) Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 379:2053–2062CrossRef
12.
Zurück zum Zitat Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327CrossRef Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318–1327CrossRef
13.
Zurück zum Zitat Marais L, Pernot M, Khettab H et al (2019) Arterial stiffness assessment by shear wave elastography and ultrafast pulse wave imaging: comparison with reference techniques in normotensives and hypertensives. Ultrasound Med Biol 45:758–772CrossRef Marais L, Pernot M, Khettab H et al (2019) Arterial stiffness assessment by shear wave elastography and ultrafast pulse wave imaging: comparison with reference techniques in normotensives and hypertensives. Ultrasound Med Biol 45:758–772CrossRef
14.
Zurück zum Zitat Mirault T, Pernot M, Frank M et al (2015) Carotid stiffness change over the cardiac cycle by ultrafast ultrasound imaging in healthy volunteers and vascular Ehlers-Danlos syndrome. J Hypertens 33:1890–1896CrossRef Mirault T, Pernot M, Frank M et al (2015) Carotid stiffness change over the cardiac cycle by ultrafast ultrasound imaging in healthy volunteers and vascular Ehlers-Danlos syndrome. J Hypertens 33:1890–1896CrossRef
15.
Zurück zum Zitat Li X, Jiang J, Zhang H et al (2007) Measurement of carotid pulse wave velocity using ultrafast ultrasound imaging in hypertensive patients. J Med Ultrason (2001) 44:183–190 Li X, Jiang J, Zhang H et al (2007) Measurement of carotid pulse wave velocity using ultrafast ultrasound imaging in hypertensive patients. J Med Ultrason (2001) 44:183–190
16.
Zurück zum Zitat Zhu ZQ, Chen LS, Wang H et al (2019) Carotid stiffness and atherosclerotic risk: non-invasive quantification with ultrafast ultrasound pulse wave velocity. Eur Radiol 29:1507–1517CrossRef Zhu ZQ, Chen LS, Wang H et al (2019) Carotid stiffness and atherosclerotic risk: non-invasive quantification with ultrafast ultrasound pulse wave velocity. Eur Radiol 29:1507–1517CrossRef
17.
Zurück zum Zitat Pan FS, Xu M, Yu L et al (2019) Relationship between carotid intima-media thickness and carotid artery stiffness assessed by ultrafast ultrasound imaging in patients with type 2 diabetes. Eur J Radiol 111:34–40CrossRef Pan FS, Xu M, Yu L et al (2019) Relationship between carotid intima-media thickness and carotid artery stiffness assessed by ultrafast ultrasound imaging in patients with type 2 diabetes. Eur J Radiol 111:34–40CrossRef
18.
Zurück zum Zitat Pan FS, Yu L, Luo J et al (2018) Carotid artery stiffness assessment by ultrafast ultrasound imaging: feasibility and potential influencing factors. J Ultrasound Med 37:2759–2767CrossRef Pan FS, Yu L, Luo J et al (2018) Carotid artery stiffness assessment by ultrafast ultrasound imaging: feasibility and potential influencing factors. J Ultrasound Med 37:2759–2767CrossRef
19.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRef Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRef
20.
Zurück zum Zitat Touboul PJ, Hennerici MG, Meairs S et al (2004) Mannheim intima-media thickness consensus. Cerebrovasc Dis 18:346–349CrossRef Touboul PJ, Hennerici MG, Meairs S et al (2004) Mannheim intima-media thickness consensus. Cerebrovasc Dis 18:346–349CrossRef
21.
Zurück zum Zitat Näslund U, Ng N, Lundgren A et al (2019) Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial. Lancet 393:133–142CrossRef Näslund U, Ng N, Lundgren A et al (2019) Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial. Lancet 393:133–142CrossRef
22.
Zurück zum Zitat Denissen SJ, van der Aalst CM, Vonder M, Oudkerk M, de Koning HJ (2019) Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial. Eur J Prev Cardiol 26:1313–1322CrossRef Denissen SJ, van der Aalst CM, Vonder M, Oudkerk M, de Koning HJ (2019) Impact of a cardiovascular disease risk screening result on preventive behaviour in asymptomatic participants of the ROBINSCA trial. Eur J Prev Cardiol 26:1313–1322CrossRef
23.
Zurück zum Zitat El Jalbout R, Cloutier G, Roy-Cardinal MH et al (2019) The value of non-invasive vascular elastography (NIVE) in detecting early vascular changes in overweight and obese children. Eur Radiol 29:3854–3861CrossRef El Jalbout R, Cloutier G, Roy-Cardinal MH et al (2019) The value of non-invasive vascular elastography (NIVE) in detecting early vascular changes in overweight and obese children. Eur Radiol 29:3854–3861CrossRef
24.
Zurück zum Zitat Roy Cardinal MH, Durand M, Chartrand-Lefebvre C et al (2020) Increased carotid artery wall stiffness and plaque prevalence in HIV infected patients measured with ultrasound elastography. Eur Radiol 30:3178–3187CrossRef Roy Cardinal MH, Durand M, Chartrand-Lefebvre C et al (2020) Increased carotid artery wall stiffness and plaque prevalence in HIV infected patients measured with ultrasound elastography. Eur Radiol 30:3178–3187CrossRef
25.
Zurück zum Zitat Wang JC, Bennett M (2012) Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 111:245–259CrossRef Wang JC, Bennett M (2012) Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res 111:245–259CrossRef
26.
Zurück zum Zitat Yu XH, Zhang DW, Zheng XL, Tang CK (2019) Cholesterol transport system: an integrated cholesterol transport model involved in atherosclerosis. Prog Lipid Res 73:65–91CrossRef Yu XH, Zhang DW, Zheng XL, Tang CK (2019) Cholesterol transport system: an integrated cholesterol transport model involved in atherosclerosis. Prog Lipid Res 73:65–91CrossRef
27.
Zurück zum Zitat Reimann C, Brangsch J, Colletini F et al (2017) Molecular imaging of the extracellular matrix in the context of atherosclerosis. Adv Drug Deliv Rev 113:49–60CrossRef Reimann C, Brangsch J, Colletini F et al (2017) Molecular imaging of the extracellular matrix in the context of atherosclerosis. Adv Drug Deliv Rev 113:49–60CrossRef
28.
Zurück zum Zitat Bonnans C, Chou J, Werb Z (2014) Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 15:786–801CrossRef Bonnans C, Chou J, Werb Z (2014) Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 15:786–801CrossRef
29.
Zurück zum Zitat Ahmadi A, Argulian E, Leipsic J, Newby DE, Narula J (2019) From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review. J Am Coll Cardiol 74:1608–1617CrossRef Ahmadi A, Argulian E, Leipsic J, Newby DE, Narula J (2019) From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review. J Am Coll Cardiol 74:1608–1617CrossRef
30.
Zurück zum Zitat Fernández-Friera L, Peñalvo JL, Fernández-Ortiz A et al (2015) Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (Progression of Early Subclinical Atherosclerosis) study. Circulation 131:2104–2113CrossRef Fernández-Friera L, Peñalvo JL, Fernández-Ortiz A et al (2015) Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (Progression of Early Subclinical Atherosclerosis) study. Circulation 131:2104–2113CrossRef
31.
Zurück zum Zitat Kassi E, Spilioti E, Nasiri-Ansari N et al (2015) Vascular inflammation and atherosclerosis: the role of estrogen receptors. Curr Med Chem 22:2651–2665CrossRef Kassi E, Spilioti E, Nasiri-Ansari N et al (2015) Vascular inflammation and atherosclerosis: the role of estrogen receptors. Curr Med Chem 22:2651–2665CrossRef
32.
Zurück zum Zitat Peters SAE, Muntner P, Woodward M (2019) Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016. Circulation 139:1025–1035CrossRef Peters SAE, Muntner P, Woodward M (2019) Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016. Circulation 139:1025–1035CrossRef
33.
Zurück zum Zitat Chen YC, Hsu BG, Lee CJ, Ho CC, Ho GJ, Lee MC (2018) Serum adipocyte fatty acid-binding protein level is associated with arterial stiffness quantified with cardio-ankle vascular index in kidney transplant patients. Clin Exp Nephrol 22:188–195 Chen YC, Hsu BG, Lee CJ, Ho CC, Ho GJ, Lee MC (2018) Serum adipocyte fatty acid-binding protein level is associated with arterial stiffness quantified with cardio-ankle vascular index in kidney transplant patients. Clin Exp Nephrol 22:188–195
34.
Zurück zum Zitat Tsiakou A, Liatis S, Alexiadou K et al (2013) Arterial stiffness is inversely related to plasma adiponectin levels in young normotensive patients with type 1 diabetes. Diabetes Care 36:734–736CrossRef Tsiakou A, Liatis S, Alexiadou K et al (2013) Arterial stiffness is inversely related to plasma adiponectin levels in young normotensive patients with type 1 diabetes. Diabetes Care 36:734–736CrossRef
35.
Zurück zum Zitat Borén J, Chapman MJ, Krauss RM et al (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. https://doi.org/10.1093/eurheartj/ehz962 Borén J, Chapman MJ, Krauss RM et al (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. https://​doi.​org/​10.​1093/​eurheartj/​ehz962
Metadaten
Titel
Absent atherosclerotic risk factors are associated with carotid stiffening quantified with ultrafast ultrasound imaging
verfasst von
Zheng-Qiu Zhu
Ling-Shan Chen
Xue-Zhong Jiang
Yi-Yun Wu
Chong Zou
Yun Luan
Hui Gao
Ping Dai
Xue-Hui Ma
Lin-Lin Wu
Hui-Juan Sun
Yin-Ping Wang
Fei Zou
Fu-Ming Liu
Hui Huang
Publikationsdatum
17.10.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2021
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-07405-4

Weitere Artikel der Ausgabe 5/2021

European Radiology 5/2021 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.